Mark M. D. Novitch is Director at KOS PHARMACEUTICALS INC (KOSP). They have made 1 open-market trade across 1 company since 2005, most recently 2006-12-13.
CIK 0001069006
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KOSP | 7,000 | — |
Shares reported on the most recent Form 4, priced at the 2006-05-02 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KOSP | SELL | 2005-08-10 | 2006-05-02 | $72.37 | $362K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.